Association of Biotechnology Led Enterprises

News

AbbVie partners Global Authorities to Determine Efficacy of HIV Drug in Treating COVID-19

Along with industry partners, the company has joined the Innovative Medicines Initiative to support research and discovery of targeted medicines against COVID-19.

Mar 12, 2020

By : Team ABLE

Novavax and Serum Institute of India to develop and commercialize Malaria Vaccine Candidate

Novavax and Serum Institute of India signed a commercial license agreement for the use of Novavax’ proprietary Matrix-M vaccine adjuvant with SII’s malaria vaccine candidate.

Mar 12, 2020

By : Team ABLE

U.S. FDA accepts Biologics License Application for Mylan and Biocon's proposed biosimilar Bevacizumab for review

Mylan and Biocon's proposed biosimilar Bevacizumab is expected to be the third biosimilar from the partnered portfolio for cancer patients in the U.S.

Mar 10, 2020

By : Team ABLE

Zydus gains exclusive rights to develop and commercialize XOMA’s IL-2 antibody

Through this collaboration, Zydus will develop the new IO drug candidate through human proof-of-concept and each company has the potential to receive pre-defined shares of future proceeds.

Mar 10, 2020

By : Team ABLE

Karnataka soon to formulate Policy on Science and Technology

Dr. C.N. Ashwath Narayan, Deputy CM of Karnataka announced that the Government of Karnataka is in the process of bringing out a Science and Technology Policy

Mar 03, 2020

By : Team ABLE